INOVIO PHARMACEUTICALS, INC. Payments of Stock Issuance Costs
INOVIO PHARMACEUTICALS, INC. (INO) reported Payments of Stock Issuance Costs of $531.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2022-05-10
- INOVIO PHARMACEUTICALS, INC. payments of stock issuance costs for the quarter ending 2021-03-31 was $531.00K.
| Period end | Payments of Stock Issuance Costs 3 month |
|---|---|
| 2021-03-31 | $531.00K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |